Orexigen Therapeutics Inc

Orexigen Therapeutics — Corporate Update (January 2018)

21 slides from Orexigen Therapeutics's corporate update, Jan 8, 2018

  1. Slide 1: January 2018 Business Update

    January, 2018 Business Update Exhibit 99.1

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements This presentation contains forward-looking statements about Orexigen Therapeutics, Inc. and its Contrave® product. Words such as “believes,” “anticipates,” “plans,” “expects,” “indicates,” “will,” “should,” “intends,” “potential,” “suggests,” “assuming,” “designed” and sim

  3. Slide 3: 2017 Performance

    2017 Performance

  4. Slide 4: Demonstrated the growth and profit potential of Contrave in the U.S.

    Demonstrated the growth and profit potential of Contrave® in the U.S. >2,000,000 prescriptions of Contrave in the U.S. since launch >100,000 physicians have prescribed Contrave in the U.S. since launch Achieved all-time highs in 2017 across multiple key prescription metrics, including total prescrip

  5. Slide 5: ~50% Higher Prescription Volume 4Q vs. 4Q

    ~50% Higher Prescription Volume 4Q 17 vs. 4Q 16 TRx Growth vs. Same Period Last Year (%) ~23% Projected Growth 2017 vs. 2016 Source: IQVIA NPA, partner provided fulfillment reports Note: *4Q 17 projections based on weekly data, monthly data not available yet ~50%* Contrave Channels include: Traditio

  6. Slide 6: Total Prescription Volume >50% Higher vs. Same Period Last Year

    Main Season No DTC Fall Season No DTC Main Season With DTC Fall Season With DTC Total Prescription Volume is >50% Higher vs. Same Period Last Year Prior to Launch of Main-Season DTC Contrave Belviq Qsymia Saxenda Source: IQVIA NPA Weekly, Week Ending 12/22/17, partner reported fulfillment reports No

  7. Slide 7: Digital/Social Campaign Metrics

    Digital/Social Campaign Metrics Key Strategic Metrics Status Status Total DTC Impressions 2.6B Digital and Social Impressions 711M Contrave.com Sessions 5.1M Contrave.com Key Actions* (%) 35% KPIs Status Status Unique Site Visitors 3.6M Find a Doctor page views 706K % of Contrave.com Sessions from S

  8. Slide 8: Significantly Grew Sales with Lower Direct Sales and Marketing Spend

    Significantly Grew Sales with a Lower Overall Direct Sales and Marketing Spend $187M $127M $95M - $105M Reps: $112M Reps: $77M Reps HCP Mktg. HCP Mktg.: $67M HCP Mktg.: $42M Patient Mktg. Note: 1. Year 1 and 2 base sales expense assume $125 per PDE with 800K and 600K PDEs, respectively with sales tr

  9. Slide 9: 2018 Initial Performance

    2018 Initial Performance

  10. Slide 10: Key Actions for 2018 Weight Loss Campaign

    Key Actions for 2018 Weight Loss Campaign Physician Promotion Increase focus on highly concentrated prescribers Evolve to new relationship model via direct accounts/patient engagement Highly efficient virtual speaker programs Focus messaging on discussing cravings with patients and treating earlier

  11. Slide 11: Strong Early Response to 2018 DTC Campaign

    Strong Early Response Week 1 of 2018 DTC Campaign Total Market Share Week 1 Performance CA/TX Fulfillments CA/TX Telemedicine/Home Delivery Fulfillments (CA/TX) Week 1 Performance Total Market Share Pages per Session Week 1 Performance* # of pages TRxs TRx Volume Week 1 Performance Pageviews Week 1

  12. Slide 12: Contrave Weekly Market Share – All Time High

    Main Season No DTC Fall Season No DTC Main Season With DTC Fall Season With DTC Contrave Weekly Market Share – All Time Market Share High Contrave Belviq Qsymia Saxenda 2016 2017 Main Season 2018 TV Campaign Started Source: IQVIA NPA Weekly, Week Ending 12/29/17, partner reported fulfillment reports

  13. Slide 13: Strong Impact on Contrave.com Traffic

    Main Season No DTC Fall Season No DTC Main Season With DTC Fall Season With DTC Strong Impact on Contrave.com Traffic Week 1 of 2018 DTC Campaign Source: Google Analytics Note: Digital and Print Ads are still active after 2nd week of May Fall Campaign started 9/10 2016 2017 Main Season 2018 TV Campa

  14. Slide 14: Telemedicine and Home Delivery Prescription Rates

    Source: Partner provided fulfillment reports Note: Digital and Print Ads are still active after 2nd week of May Fall Campaign started 9/10 Telemedicine and Home Delivery New Prescription and Refill Rates Supported by Customer Service Model Week Ending Fall TV Campaign Started Contrave “Get Contrave

  15. Slide 15: Projected TRx Volume: Contrave

    Projected TRx Volume: Contrave TRxs 2016 2017 2018 Source: IQVIA Nov 2017, partner provided fulfillment reports, Orexigen Estimates Dec 2017 – Dec 2018 1,315K 1,100K 691K 847K 4Q16 vs. 4Q17: +~50% +30% +55% Contrave Channels include: Traditional + Home Delivery + Telemedicine

  16. Slide 16: Contrave and phentermine are top two choices among HCPs

    Contrave and phentermine have become the top two choices among HCPs When thinking about prescription medications to treat obesity, what one medication first comes to mind? In the next month, how likely are to write a prescription for each of the following medications for adult patients who are strug

  17. Slide 17: Launched in 23 OUS Countries

    Submissions Launches 1Q 18 4Q 17 3Q 17 2Q 17 1Q 17 4Q 16 3Q 16 2Q 16 Saudi Arabia Lebanon UAE Canada Serbia Malta South Africa Saudi Arabia Australia Canada Lebanon UAE Kuwait Greece United Kingdom Ireland Spain Bulgaria Estonia Lithuania Latvia Croatia Slovenia Korea Czech Republic Slovakia Hungary

  18. Slide 18: 2018 Strategic Objectives

    Execute 2018 commercial plan in the United States to continue to drive Contrave prescription and revenue growth Support partners’ advancement of launches and regulatory filings in countries outside the United States Continue positive dialog with regulators regarding completion of post-marketing requ

  19. Slide 19: Backup

    Backup

  20. Slide 20: Digital/Social Strategy Rollout

    1H 2017 2H 2017 1H 2018 Paid Video & Banner Pinterest Pilot Launch Website Launch Facebook/ Instagram Page Launch Paid Get Contrave Now(GCN) Facebook Digital/Social Strategy Rollout Fall Campaign New CTA Summer Bodies Social Campaign Cross Device Marketing Twitter Pilot Customized Video Site Retarge

  21. Slide 21: Telemedicine and Free Home Delivery available in states

    Telemedicine and Free Home Delivery available in 50 states Legend: Two partners (90% of TRx vol) One partner (10% of TRx vol)

Orexigen Therapeutics — Corporate Update (January 2018) on 6ix